MBB1A_HUMAN - dbPTM
MBB1A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MBB1A_HUMAN
UniProt AC Q9BQG0
Protein Name Myb-binding protein 1A
Gene Name MYBBP1A
Organism Homo sapiens (Human).
Sequence Length 1328
Subcellular Localization Cytoplasm . Nucleus . Nucleus, nucleolus . Shuttles between the nucleus and cytoplasm. Nuclear import may be mediated by KPNA2, while export appears to depend partially on XPO1/CRM1 (By similarity). Predominantly nucleolar.
Protein Description May activate or repress transcription via interactions with sequence specific DNA-binding proteins. Repression may be mediated at least in part by histone deacetylase activity (HDAC activity). Acts as a corepressor and in concert with CRY1, represses the transcription of the core circadian clock component PER2. Preferentially binds to dimethylated histone H3 'Lys-9' (H3K9me2) on the PER2 promoter..
Protein Sequence MESRDPAQPMSPGEATQSGARPADRYGLLKHSREFLDFFWDIAKPEQETRLAATEKLLEYLRGRPKGSEMKYALKRLITGLGVGRETARPCYSLALAQLLQSFEDLPLCSILQQIQEKYDLHQVKKAMLRPALFANLFGVLALFQSGRLVKDQEALMKSVKLLQALAQYQNHLQEQPRKALVDILSEVSKATLQEILPEVLKADLNIILSSPEQLELFLLAQQKVPSKLKKLVGSVNLFSDENVPRLVNVLKMAASSVKKDRKLPAIALDLLRLALKEDKFPRFWKEVVEQGLLKMQFWPASYLCFRLLGAALPLLTKEQLHLVMQGDVIRHYGEHVCTAKLPKQFKFAPEMDDYVGTFLEGCQDDPERQLAVLVAFSSVTNQGLPVTPTFWRVVRFLSPPALQGYVAWLRAMFLQPDLDSLVDFSTNNQKKAQDSSLHMPERAVFRLRKWIIFRLVSIVDSLHLEMEEALTEQVARFCLFHSFFVTKKPTSQIPETKHPFSFPLENQAREAVSSAFFSLLQTLSTQFKQAPGQTQGGQPWTYHLVQFADLLLNHSHNVTTVTPFTAQQRQAWDRMLQTLKELEAHSAEARAAAFQHLLLLVGIHLLKSPAESCDLLGDIQTCIRKSLGEKPRRSRTKTIDPQEPPWVEVLVEILLALLAQPSHLMRQVARSVFGHICSHLTPRALQLILDVLNPETSEDENDRVVVTDDSDERRLKGAEDKSEEGEDNRSSESEEESEGEESEEEERDGDVDQGFREQLMTVLQAGKALGGEDSENEEELGDEAMMALDQSLASLFAEQKLRIQARRDEKNKLQKEKALRRDFQIRVLDLVEVLVTKQPENALVLELLEPLLSIIRRSLRSSSSKQEQDLLHKTARIFTHHLCRARRYCHDLGERAGALHAQVERLVQQAGRQPDSPTALYHFNASLYLLRVLKGNTAEGCVHETQEKQKAGTDPSHMPTGPQAASCLDLNLVTRVYSTALSSFLTKRNSPLTVPMFLSLFSRHPVLCQSLLPILVQHITGPVRPRHQACLLLQKTLSMREVRSCFEDPEWKQLMGQVLAKVTENLRVLGEAQTKAQHQQALSSLELLNVLFRTCKHEKLTLDLTVLLGVLQGQQQSLQQGAHSTGSSRLHDLYWQAMKTLGVQRPKLEKKDAKEIPSATQSPISKKRKKKGFLPETKKRKKRKSEDGTPAEDGTPAATGGSQPPSMGRKKRNRTKAKVPAQANGTPTTKSPAPGAPTRSPSTPAKSPKLQKKNQKPSQVNGAPGSPTEPAGQKQHQKALPKKGVLGKSPLSALARKKARLSLVIRSPSLLQSGAKKKAQVRKAGKP
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MESRDPAQ
-------CCCCCCCC
44.98-
3Phosphorylation-----MESRDPAQPM
-----CCCCCCCCCC
54.5726074081
10SulfoxidationSRDPAQPMSPGEATQ
CCCCCCCCCCCCCCC
5.1221406390
11PhosphorylationRDPAQPMSPGEATQS
CCCCCCCCCCCCCCC
36.1119664994
11 (in isoform 2)Phosphorylation-36.1124719451
16PhosphorylationPMSPGEATQSGARPA
CCCCCCCCCCCCCCH
20.9723927012
16 (in isoform 2)Phosphorylation-20.9721406692
18PhosphorylationSPGEATQSGARPADR
CCCCCCCCCCCCHHH
30.0225159151
18 (in isoform 2)Phosphorylation-30.0221406692
26PhosphorylationGARPADRYGLLKHSR
CCCCHHHHHCHHHHH
16.8124732914
30AcetylationADRYGLLKHSREFLD
HHHHHCHHHHHHHHH
44.5726051181
30MethylationADRYGLLKHSREFLD
HHHHHCHHHHHHHHH
44.57115973417
30UbiquitinationADRYGLLKHSREFLD
HHHHHCHHHHHHHHH
44.5729967540
30 (in isoform 2)Ubiquitination-44.57-
32PhosphorylationRYGLLKHSREFLDFF
HHHCHHHHHHHHHHH
31.7326074081
44UbiquitinationDFFWDIAKPEQETRL
HHHHHHCCHHHHHHH
49.80-
49PhosphorylationIAKPEQETRLAATEK
HCCHHHHHHHHHHHH
30.5821406692
54PhosphorylationQETRLAATEKLLEYL
HHHHHHHHHHHHHHH
28.2221406692
56AcetylationTRLAATEKLLEYLRG
HHHHHHHHHHHHHCC
54.7625953088
56UbiquitinationTRLAATEKLLEYLRG
HHHHHHHHHHHHHCC
54.7621963094
56 (in isoform 1)Ubiquitination-54.7621890473
56 (in isoform 2)Ubiquitination-54.7621890473
60PhosphorylationATEKLLEYLRGRPKG
HHHHHHHHHCCCCCC
11.1517081983
71AcetylationRPKGSEMKYALKRLI
CCCCHHHHHHHHHHH
24.2619608861
71UbiquitinationRPKGSEMKYALKRLI
CCCCHHHHHHHHHHH
24.2629967540
71 (in isoform 2)Ubiquitination-24.26-
79PhosphorylationYALKRLITGLGVGRE
HHHHHHHHHCCCCHH
30.83-
93O-linked_GlycosylationETARPCYSLALAQLL
HHHHHHHHHHHHHHH
17.5529351928
95UbiquitinationARPCYSLALAQLLQS
HHHHHHHHHHHHHHH
8.5621963094
102O-linked_GlycosylationALAQLLQSFEDLPLC
HHHHHHHHCCCCCHH
30.4929351928
125AcetylationKYDLHQVKKAMLRPA
HCCHHHHHHHHHHHH
28.3926051181
125UbiquitinationKYDLHQVKKAMLRPA
HCCHHHHHHHHHHHH
28.3933845483
128SulfoxidationLHQVKKAMLRPALFA
HHHHHHHHHHHHHHH
4.4728183972
151UbiquitinationFQSGRLVKDQEALMK
HHCCCCCCCHHHHHH
59.28-
151 (in isoform 2)Ubiquitination-59.28-
157SulfoxidationVKDQEALMKSVKLLQ
CCCHHHHHHHHHHHH
3.8121406390
158AcetylationKDQEALMKSVKLLQA
CCHHHHHHHHHHHHH
53.6119608861
158MalonylationKDQEALMKSVKLLQA
CCHHHHHHHHHHHHH
53.6126320211
158UbiquitinationKDQEALMKSVKLLQA
CCHHHHHHHHHHHHH
53.6122817900
161UbiquitinationEALMKSVKLLQALAQ
HHHHHHHHHHHHHHH
51.0421890473
161 (in isoform 1)Ubiquitination-51.0421890473
161 (in isoform 2)Ubiquitination-51.0421890473
169PhosphorylationLLQALAQYQNHLQEQ
HHHHHHHHHHHHHHC
12.9928152594
179AcetylationHLQEQPRKALVDILS
HHHHCHHHHHHHHHH
53.4026051181
179UbiquitinationHLQEQPRKALVDILS
HHHHCHHHHHHHHHH
53.4022817900
179 (in isoform 1)Ubiquitination-53.4021890473
179 (in isoform 2)Ubiquitination-53.4021890473
186PhosphorylationKALVDILSEVSKATL
HHHHHHHHHHCHHHH
35.96-
189PhosphorylationVDILSEVSKATLQEI
HHHHHHHCHHHHHHH
16.7220071362
228UbiquitinationAQQKVPSKLKKLVGS
HHCCCCHHHHHHHCC
59.2522817900
230UbiquitinationQKVPSKLKKLVGSVN
CCCCHHHHHHHCCCC
48.0422817900
231MalonylationKVPSKLKKLVGSVNL
CCCHHHHHHHCCCCC
59.8626320211
231UbiquitinationKVPSKLKKLVGSVNL
CCCHHHHHHHCCCCC
59.8622817900
231 (in isoform 1)Ubiquitination-59.8621890473
231 (in isoform 2)Ubiquitination-59.8621890473
252AcetylationPRLVNVLKMAASSVK
HHHHHHHHHHHHHCC
23.3925953088
252UbiquitinationPRLVNVLKMAASSVK
HHHHHHHHHHHHHCC
23.3924816145
259AcetylationKMAASSVKKDRKLPA
HHHHHHCCCCCCCCH
51.4025953088
277UbiquitinationDLLRLALKEDKFPRF
HHHHHHHHCCCCHHH
59.25-
286AcetylationDKFPRFWKEVVEQGL
CCCHHHHHHHHHHCC
37.6126051181
302PhosphorylationKMQFWPASYLCFRLL
HHCCCCHHHHHHHHH
17.9820068231
303PhosphorylationMQFWPASYLCFRLLG
HCCCCHHHHHHHHHH
15.0320068231
329UbiquitinationHLVMQGDVIRHYGEH
HHHHCCCHHHHHCCC
5.4624816145
333PhosphorylationQGDVIRHYGEHVCTA
CCCHHHHHCCCEEEC
17.8528152594
341AcetylationGEHVCTAKLPKQFKF
CCCEEECCCCCCCCC
47.3625953088
341UbiquitinationGEHVCTAKLPKQFKF
CCCEEECCCCCCCCC
47.3632015554
341 (in isoform 2)Ubiquitination-47.36-
347UbiquitinationAKLPKQFKFAPEMDD
CCCCCCCCCCCCCCC
37.8221963094
363GlutathionylationVGTFLEGCQDDPERQ
HHHHHHHCCCCHHHH
2.6822555962
374UbiquitinationPERQLAVLVAFSSVT
HHHHHHHHHHHHHHC
1.5924816145
399PhosphorylationWRVVRFLSPPALQGY
HHHHHHHCCHHHHHH
26.56-
413SulfoxidationYVAWLRAMFLQPDLD
HHHHHHHHHHCCCHH
2.5228183972
421PhosphorylationFLQPDLDSLVDFSTN
HHCCCHHHHCCCCCC
37.2720873877
426O-linked_GlycosylationLDSLVDFSTNNQKKA
HHHHCCCCCCCHHHH
26.2629351928
426PhosphorylationLDSLVDFSTNNQKKA
HHHHCCCCCCCHHHH
26.2620873877
427O-linked_GlycosylationDSLVDFSTNNQKKAQ
HHHCCCCCCCHHHHC
37.8829351928
432UbiquitinationFSTNNQKKAQDSSLH
CCCCCHHHHCCCCCC
41.33-
432 (in isoform 2)Ubiquitination-41.33-
450AcetylationRAVFRLRKWIIFRLV
HHHHHHHHHHHHHHH
47.5426051181
487PhosphorylationLFHSFFVTKKPTSQI
HHHHHHCCCCCCCCC
28.35-
488AcetylationFHSFFVTKKPTSQIP
HHHHHCCCCCCCCCC
51.9926051181
489AcetylationHSFFVTKKPTSQIPE
HHHHCCCCCCCCCCC
44.1326051181
491PhosphorylationFFVTKKPTSQIPETK
HHCCCCCCCCCCCCC
41.9925850435
492PhosphorylationFVTKKPTSQIPETKH
HCCCCCCCCCCCCCC
34.3425849741
497PhosphorylationPTSQIPETKHPFSFP
CCCCCCCCCCCCCCC
29.3325850435
498AcetylationTSQIPETKHPFSFPL
CCCCCCCCCCCCCCC
47.8525953088
498UbiquitinationTSQIPETKHPFSFPL
CCCCCCCCCCCCCCC
47.85-
502PhosphorylationPETKHPFSFPLENQA
CCCCCCCCCCCCHHH
30.3323312004
514PhosphorylationNQAREAVSSAFFSLL
HHHHHHHHHHHHHHH
24.0121601212
523PhosphorylationAFFSLLQTLSTQFKQ
HHHHHHHHHHHHHHC
23.7321601212
561UbiquitinationNHSHNVTTVTPFTAQ
HCCCCCCEECCCCHH
20.3524816145
581AcetylationDRMLQTLKELEAHSA
HHHHHHHHHHHHCCH
64.7426051181
581UbiquitinationDRMLQTLKELEAHSA
HHHHHHHHHHHHCCH
64.7424816145
581 (in isoform 1)Ubiquitination-64.7421890473
581 (in isoform 2)Ubiquitination-64.7421890473
591MethylationEAHSAEARAAAFQHL
HHCCHHHHHHHHHHH
19.10115388349
613PhosphorylationLLKSPAESCDLLGDI
HHCCHHHHCCHHHHH
18.2925159151
614UbiquitinationLKSPAESCDLLGDIQ
HCCHHHHCCHHHHHH
3.0024816145
626UbiquitinationDIQTCIRKSLGEKPR
HHHHHHHHHCCCCCC
30.0724816145
631AcetylationIRKSLGEKPRRSRTK
HHHHCCCCCCCCCCC
41.8623749302
631UbiquitinationIRKSLGEKPRRSRTK
HHHHCCCCCCCCCCC
41.8629967540
635PhosphorylationLGEKPRRSRTKTIDP
CCCCCCCCCCCCCCC
45.6517081983
637PhosphorylationEKPRRSRTKTIDPQE
CCCCCCCCCCCCCCC
33.5129759185
663PhosphorylationLALLAQPSHLMRQVA
HHHHCCHHHHHHHHH
19.71-
672PhosphorylationLMRQVARSVFGHICS
HHHHHHHHHHHHHHH
16.4420873877
683UbiquitinationHICSHLTPRALQLIL
HHHHCCCHHHHHHHH
26.3821963094
697PhosphorylationLDVLNPETSEDENDR
HHHHCCCCCCCCCCC
38.3829116813
698PhosphorylationDVLNPETSEDENDRV
HHHCCCCCCCCCCCE
41.1920873877
708PhosphorylationENDRVVVTDDSDERR
CCCCEEECCCHHHHH
23.6021815630
711PhosphorylationRVVVTDDSDERRLKG
CEEECCCHHHHHHCC
44.1525849741
723PhosphorylationLKGAEDKSEEGEDNR
HCCCCCCCCCCCCCC
53.8825137130
731PhosphorylationEEGEDNRSSESEEES
CCCCCCCCCCCCCHH
44.7225137130
732PhosphorylationEGEDNRSSESEEESE
CCCCCCCCCCCCHHC
41.7425137130
734PhosphorylationEDNRSSESEEESEGE
CCCCCCCCCCHHCCC
52.8625137130
736UbiquitinationNRSSESEEESEGEES
CCCCCCCCHHCCCCC
75.9021890473
738PhosphorylationSSESEEESEGEESEE
CCCCCCHHCCCCCHH
54.9325137130
743PhosphorylationEESEGEESEEEERDG
CHHCCCCCHHHHHCC
46.1125137130
761SulfoxidationQGFREQLMTVLQAGK
HHHHHHHHHHHHHHH
2.1421406390
775PhosphorylationKALGGEDSENEEELG
HHHCCCCCCCHHHHH
37.7125159151
775 (in isoform 2)Phosphorylation-37.7124719451
784UbiquitinationNEEELGDEAMMALDQ
CHHHHHHHHHHHHHH
36.3421890473
792PhosphorylationAMMALDQSLASLFAE
HHHHHHHHHHHHHHH
26.1025159151
795PhosphorylationALDQSLASLFAEQKL
HHHHHHHHHHHHHHH
29.3430175587
813UbiquitinationARRDEKNKLQKEKAL
HHHHHHHHHHHHHHH
64.4624816145
859PhosphorylationLLSIIRRSLRSSSSK
HHHHHHHHHHCCCCH
20.48-
862PhosphorylationIIRRSLRSSSSKQEQ
HHHHHHHCCCCHHHH
39.6120873877
863PhosphorylationIRRSLRSSSSKQEQD
HHHHHHCCCCHHHHH
32.0020873877
864PhosphorylationRRSLRSSSSKQEQDL
HHHHHCCCCHHHHHH
42.6820873877
865PhosphorylationRSLRSSSSKQEQDLL
HHHHCCCCHHHHHHH
40.0622210691
866UbiquitinationSLRSSSSKQEQDLLH
HHHCCCCHHHHHHHH
60.8624816145
866 (in isoform 2)Ubiquitination-60.86-
874UbiquitinationQEQDLLHKTARIFTH
HHHHHHHHHHHHHHH
43.80-
874 (in isoform 2)Ubiquitination-43.80-
888UbiquitinationHHLCRARRYCHDLGE
HHHHHHHHHHHHHHH
37.1321890473
889PhosphorylationHLCRARRYCHDLGER
HHHHHHHHHHHHHHH
6.6528152594
896MethylationYCHDLGERAGALHAQ
HHHHHHHHHCHHHHH
36.20115484091
920UbiquitinationRQPDSPTALYHFNAS
CCCCCCCHHHHHHHH
14.9824816145
933UbiquitinationASLYLLRVLKGNTAE
HHHHHHHHHCCCCCC
6.9924816145
935AcetylationLYLLRVLKGNTAEGC
HHHHHHHCCCCCCCC
47.4626822725
935UbiquitinationLYLLRVLKGNTAEGC
HHHHHHHCCCCCCCC
47.4621963094
935 (in isoform 2)Ubiquitination-47.46-
942GlutathionylationKGNTAEGCVHETQEK
CCCCCCCCCCCHHHH
1.8122555962
946PhosphorylationAEGCVHETQEKQKAG
CCCCCCCHHHHHHCC
27.4425159151
949AcetylationCVHETQEKQKAGTDP
CCCCHHHHHHCCCCC
47.4826051181
949UbiquitinationCVHETQEKQKAGTDP
CCCCHHHHHHCCCCC
47.4829967540
967UbiquitinationPTGPQAASCLDLNLV
CCCHHHHHHHCHHHH
20.4424816145
968GlutathionylationTGPQAASCLDLNLVT
CCHHHHHHHCHHHHH
2.6922555962
978PhosphorylationLNLVTRVYSTALSSF
HHHHHHHHHHHHHHH
9.3024719451
978 (in isoform 2)Phosphorylation-9.3024719451
979PhosphorylationNLVTRVYSTALSSFL
HHHHHHHHHHHHHHH
12.3528152594
980PhosphorylationLVTRVYSTALSSFLT
HHHHHHHHHHHHHHH
17.5824719451
980 (in isoform 2)Phosphorylation-17.5824719451
983PhosphorylationRVYSTALSSFLTKRN
HHHHHHHHHHHHHCC
19.3120860994
984PhosphorylationVYSTALSSFLTKRNS
HHHHHHHHHHHHCCC
25.7321406692
987PhosphorylationTALSSFLTKRNSPLT
HHHHHHHHHCCCCCH
26.4120860994
987 (in isoform 2)Phosphorylation-26.4121406692
988AcetylationALSSFLTKRNSPLTV
HHHHHHHHCCCCCHH
52.2925953088
988UbiquitinationALSSFLTKRNSPLTV
HHHHHHHHCCCCCHH
52.2921890473
988 (in isoform 1)Ubiquitination-52.2921890473
988 (in isoform 2)Ubiquitination-52.2921890473
991PhosphorylationSFLTKRNSPLTVPMF
HHHHHCCCCCHHHHH
25.8927461979
994PhosphorylationTKRNSPLTVPMFLSL
HHCCCCCHHHHHHHH
26.4127461979
994 (in isoform 2)Phosphorylation-26.4124719451
1000PhosphorylationLTVPMFLSLFSRHPV
CHHHHHHHHHHCCHH
18.9927461979
1003PhosphorylationPMFLSLFSRHPVLCQ
HHHHHHHHCCHHHHH
34.6727461979
1011PhosphorylationRHPVLCQSLLPILVQ
CCHHHHHHHHHHHHH
30.77-
1021PhosphorylationPILVQHITGPVRPRH
HHHHHHCCCCCCHHH
33.05-
1031S-nitrosocysteineVRPRHQACLLLQKTL
CCHHHHHHHHHHHHC
1.90-
1031S-nitrosylationVRPRHQACLLLQKTL
CCHHHHHHHHHHHHC
1.9019483679
1036AcetylationQACLLLQKTLSMREV
HHHHHHHHHCCHHHH
51.9426051181
1036UbiquitinationQACLLLQKTLSMREV
HHHHHHHHHCCHHHH
51.9421890473
1036 (in isoform 1)Ubiquitination-51.9421890473
1036 (in isoform 2)Ubiquitination-51.9421890473
1046GlutathionylationSMREVRSCFEDPEWK
CHHHHHHHCCCHHHH
2.8022555962
1053AcetylationCFEDPEWKQLMGQVL
HCCCHHHHHHHHHHH
31.7126051181
1053UbiquitinationCFEDPEWKQLMGQVL
HCCCHHHHHHHHHHH
31.7129967540
1062AcetylationLMGQVLAKVTENLRV
HHHHHHHHHHHHHHH
45.5926051181
1062UbiquitinationLMGQVLAKVTENLRV
HHHHHHHHHHHHHHH
45.59-
1062 (in isoform 2)Ubiquitination-45.59-
1067UbiquitinationLAKVTENLRVLGEAQ
HHHHHHHHHHHHHHH
3.0524816145
1139SulfoxidationHDLYWQAMKTLGVQR
HHHHHHHHHHHCCCC
1.7228183972
1140AcetylationDLYWQAMKTLGVQRP
HHHHHHHHHHCCCCC
43.5526051181
1140UbiquitinationDLYWQAMKTLGVQRP
HHHHHHHHHHCCCCC
43.5522817900
1140 (in isoform 1)Ubiquitination-43.5521890473
1140 (in isoform 2)Ubiquitination-43.5521890473
1148SumoylationTLGVQRPKLEKKDAK
HHCCCCCCCCCCCHH
72.0428112733
1148UbiquitinationTLGVQRPKLEKKDAK
HHCCCCCCCCCCCHH
72.0429967540
1155AcetylationKLEKKDAKEIPSATQ
CCCCCCHHHCCCCCC
67.3326051181
1155UbiquitinationKLEKKDAKEIPSATQ
CCCCCCHHHCCCCCC
67.3329967540
1159PhosphorylationKDAKEIPSATQSPIS
CCHHHCCCCCCCCCC
50.0029255136
1159 (in isoform 2)Phosphorylation-50.0024719451
1161PhosphorylationAKEIPSATQSPISKK
HHHCCCCCCCCCCHH
33.6429255136
1161 (in isoform 2)Phosphorylation-33.6421406692
1163PhosphorylationEIPSATQSPISKKRK
HCCCCCCCCCCHHHH
21.6119664994
1163 (in isoform 2)Phosphorylation-21.6124719451
1166PhosphorylationSATQSPISKKRKKKG
CCCCCCCCHHHHHCC
35.1929255136
1167AcetylationATQSPISKKRKKKGF
CCCCCCCHHHHHCCC
58.2725953088
1172UbiquitinationISKKRKKKGFLPETK
CCHHHHHCCCCCHHH
58.9124816145
1178PhosphorylationKKGFLPETKKRKKRK
HCCCCCHHHHCCCCC
39.6724173317
1179AcetylationKGFLPETKKRKKRKS
CCCCCHHHHCCCCCC
49.2525953088
1185AcetylationTKKRKKRKSEDGTPA
HHHCCCCCCCCCCCC
68.0526051181
1185UbiquitinationTKKRKKRKSEDGTPA
HHHCCCCCCCCCCCC
68.0524816145
1186PhosphorylationKKRKKRKSEDGTPAE
HHCCCCCCCCCCCCC
44.9830266825
1186 (in isoform 2)Phosphorylation-44.9824719451
1190PhosphorylationKRKSEDGTPAEDGTP
CCCCCCCCCCCCCCC
31.4830266825
1196PhosphorylationGTPAEDGTPAATGGS
CCCCCCCCCCCCCCC
23.2930266825
1196 (in isoform 2)Phosphorylation-23.2927251275
1200PhosphorylationEDGTPAATGGSQPPS
CCCCCCCCCCCCCCC
44.1523927012
1203PhosphorylationTPAATGGSQPPSMGR
CCCCCCCCCCCCCCC
40.6423927012
1207PhosphorylationTGGSQPPSMGRKKRN
CCCCCCCCCCCCCCC
40.3223927012
1208SulfoxidationGGSQPPSMGRKKRNR
CCCCCCCCCCCCCCC
8.1021406390
1219AcetylationKRNRTKAKVPAQANG
CCCCCCCCCCCCCCC
50.7525953088
1219UbiquitinationKRNRTKAKVPAQANG
CCCCCCCCCCCCCCC
50.7524816145
1227PhosphorylationVPAQANGTPTTKSPA
CCCCCCCCCCCCCCC
19.7830266825
1227 (in isoform 2)Phosphorylation-19.7827251275
1229PhosphorylationAQANGTPTTKSPAPG
CCCCCCCCCCCCCCC
46.8530266825
1230PhosphorylationQANGTPTTKSPAPGA
CCCCCCCCCCCCCCC
30.6330266825
1231AcetylationANGTPTTKSPAPGAP
CCCCCCCCCCCCCCC
57.8525953088
1232PhosphorylationNGTPTTKSPAPGAPT
CCCCCCCCCCCCCCC
24.9730266825
1232 (in isoform 2)Phosphorylation-24.9721406692
1239PhosphorylationSPAPGAPTRSPSTPA
CCCCCCCCCCCCCCC
43.1523927012
1239 (in isoform 2)Phosphorylation-43.1521406692
1241PhosphorylationAPGAPTRSPSTPAKS
CCCCCCCCCCCCCCC
26.1925159151
1241 (in isoform 2)Phosphorylation-26.1924719451
1243PhosphorylationGAPTRSPSTPAKSPK
CCCCCCCCCCCCCHH
48.5530266825
1244PhosphorylationAPTRSPSTPAKSPKL
CCCCCCCCCCCCHHH
30.5630266825
1244 (in isoform 2)Phosphorylation-30.5624719451
1247AcetylationRSPSTPAKSPKLQKK
CCCCCCCCCHHHHHC
69.3725953088
1248PhosphorylationSPSTPAKSPKLQKKN
CCCCCCCCHHHHHCC
29.4025159151
1259PhosphorylationQKKNQKPSQVNGAPG
HHCCCCCCCCCCCCC
54.5229255136
1267PhosphorylationQVNGAPGSPTEPAGQ
CCCCCCCCCCCCCCH
27.8219664994
1267 (in isoform 2)Phosphorylation-27.8224719451
1269PhosphorylationNGAPGSPTEPAGQKQ
CCCCCCCCCCCCHHH
57.1922167270
1269 (in isoform 2)Phosphorylation-57.1921406692
1284AcetylationHQKALPKKGVLGKSP
HHHHCCCCCCCCCCH
52.9225953088
1289AcetylationPKKGVLGKSPLSALA
CCCCCCCCCHHHHHH
44.7525953088
1290PhosphorylationKKGVLGKSPLSALAR
CCCCCCCCHHHHHHH
29.3129255136
1290 (in isoform 2)Phosphorylation-29.3124719451
1293PhosphorylationVLGKSPLSALARKKA
CCCCCHHHHHHHHHH
25.3123927012
1293 (in isoform 2)Phosphorylation-25.3124719451
1303PhosphorylationARKKARLSLVIRSPS
HHHHHHHHHHHCCHH
18.2925159151
1303 (in isoform 2)Phosphorylation-18.2924719451
1307CitrullinationARLSLVIRSPSLLQS
HHHHHHHCCHHHHHC
34.73-
1307CitrullinationARLSLVIRSPSLLQS
HHHHHHHCCHHHHHC
34.73-
1308O-linked_GlycosylationRLSLVIRSPSLLQSG
HHHHHHCCHHHHHCC
14.0229351928
1308PhosphorylationRLSLVIRSPSLLQSG
HHHHHHCCHHHHHCC
14.0229255136
1308 (in isoform 2)Phosphorylation-14.0229743597
1310PhosphorylationSLVIRSPSLLQSGAK
HHHHCCHHHHHCCHH
42.8529255136
1310 (in isoform 2)Phosphorylation-42.8524719451
1314PhosphorylationRSPSLLQSGAKKKAQ
CCHHHHHCCHHHHHH
40.4625159151
1314 (in isoform 2)Phosphorylation-40.4629743597
1317AcetylationSLLQSGAKKKAQVRK
HHHHCCHHHHHHHHH
59.3325953088
1319AcetylationLQSGAKKKAQVRKAG
HHCCHHHHHHHHHCC
43.2619824341
1319UbiquitinationLQSGAKKKAQVRKAG
HHCCHHHHHHHHHCC
43.2624816145

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
1303SPhosphorylationKinaseAURKAO14965
GPS
1303SPhosphorylationKinaseAURKBQ96GD4
GPS
1310SPhosphorylationKinaseCHEK1O14757
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MBB1A_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MBB1A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
AIRE_HUMANAIREphysical
20085707
VHL_HUMANVHLphysical
21386990
ELOC_HUMANTCEB1physical
21386990
ELOB_HUMANTCEB2physical
21386990
TAF1D_HUMANTAF1Dphysical
21386990
NOP2_HUMANNOP2physical
21386990
NUCL_HUMANNCLphysical
21386990
LYAR_HUMANLYARphysical
21386990
RIOX2_HUMANMINAphysical
21386990
BOP1_HUMANBOP1physical
21386990
SIR7_HUMANSIRT7physical
22147730
UBF1_HUMANUBTFphysical
22147730
SMCA5_HUMANSMARCA5physical
22147730
RPA1_HUMANPOLR1Aphysical
22147730
SIR7_HUMANSIRT7physical
22586326
RPA1_HUMANPOLR1Aphysical
22586326
SMCA5_HUMANSMARCA5physical
22586326
UBF1_HUMANUBTFphysical
22586326
A4_HUMANAPPphysical
21832049
RL7_HUMANRPL7physical
22939629
RL4_HUMANRPL4physical
22939629
RL6_HUMANRPL6physical
22939629
RS3_HUMANRPS3physical
22939629
RS13_HUMANRPS13physical
22939629
RL23A_HUMANRPL23Aphysical
22939629
RS6_HUMANRPS6physical
22939629
RL37A_HUMANRPL37Aphysical
22939629
RL1D1_HUMANRSL1D1physical
22939629
RL18_HUMANRPL18physical
22939629
RS2_HUMANRPS2physical
22939629
RL5_HUMANRPL5physical
22939629
RS11_HUMANRPS11physical
22939629
RS14_HUMANRPS14physical
22939629
RS24_HUMANRPS24physical
22939629
RS23_HUMANRPS23physical
22939629
RS8_HUMANRPS8physical
22939629
RNPS1_HUMANRNPS1physical
22939629
SPB1_HUMANFTSJ3physical
22939629
RED_HUMANIKphysical
22939629
RRS1_HUMANRRS1physical
22939629
RRP7A_HUMANRRP7Aphysical
22939629
CAVN1_HUMANPTRFphysical
22939629
NOP16_HUMANNOP16physical
22939629
SND1_HUMANSND1physical
22939629
ROA0_HUMANHNRNPA0physical
22939629
MCM5_HUMANMCM5physical
22939629
NICA_HUMANNCSTNphysical
22939629
TF65_HUMANRELAphysical
24175631
PRP8_HUMANPRPF8physical
26344197
ZN746_HUMANZNF746physical
25315684

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MBB1A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-711; SER-775;SER-1163; THR-1227; SER-1232; SER-1290; SER-1308; SER-1310 ANDSER-1314, ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASSSPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-71 AND LYS-158, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775; SER-1163; SER-1267AND SER-1310, AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1159; THR-1161;SER-1163; THR-1196; SER-1207; THR-1227; SER-1267 AND THR-1269, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775; SER-1159;SER-1163; SER-1186; THR-1190; THR-1196; SER-1207; SER-1241; THR-1244;SER-1248; SER-1267; SER-1290; SER-1293; SER-1303; SER-1308 ANDSER-1314, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-775; SER-1159;THR-1161; SER-1163; THR-1227; SER-1267 AND SER-1290, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1186 AND THR-1190, ANDMASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1163 AND SER-1166, ANDMASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-711; SER-775;SER-1163; THR-1227; SER-1232; SER-1290; SER-1308; SER-1310 ANDSER-1314, ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1290; SER-1293; SER-1308AND SER-1314, AND MASS SPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-775; SER-1163 ANDSER-1267, AND MASS SPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; SER-1159; SER-1163;SER-1290; SER-1308 AND SER-1314, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-11; TYR-60; SER-775 ANDSER-1267, AND MASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1163, AND MASSSPECTROMETRY.

TOP